|
Ventana is uniquely capable of developing and communicating these new food choices in the context of general health and nutrition education highlighted by on research and product development.
The need for natural healthy products that address the growing overweight and diabetic general populations is reflected in the following table:
| Consumer Information |
United States |
| Population |
287,000,000 |
| % Adults Overweight |
67% |
| % Children & Adolescents Overweight |
25% |
| Overweight |
192,300,000 |
| Individuals with Diabetes |
17,000,000 |
| Estimated Diabetics 2050 |
29,000,000 |
| Incidence of Diabetes (age 45-64) |
7.8% |
| Incidence of Diabetes by Age 65 |
12.0% |
- UCLA Center for Health Policy Research
- US Centers for Disease Control and Prevention (October 2003, Nutraceuticals World)
The U.S., and particularly the Latino segment, is facing an ever-increasing obesity and diabetes problem. Experts agree that the diabetic problems are often traced to the over weight condition of the patient.
The U.S. Surgeon General has declared that obesity has replaced smoking as the leading health risk to Americans—and it is a worldwide epidemic.
“Food Technology” (April 2003) highlights Ventana weight loss opportunities:
Health-motivated diet segment
Need for products directed at children (only 1 of 3 teens is satisfied with their weight)
Timing is right for a new generation of low-/high-micro and macronutrient products aimed at
weight loss
Amount of weight needed to be lost is the highest in history
Ventana’s long-term objectives are to develop a series of products and services in support of the “Window on Health”—a lifestyle of health and sustainability for the Latino population.

Erythritol: A new All-Natural and Noncaloric Bulk Sweetener - VIEW
Effects of Oral Administration of Erythritol on Patients with Diabetes - VIEW
Erythritol: A Review of Biological and Toxicological Studies - VIEW
Erythritol: An Interpretive Summary of
Biochemical, Metabolic, Toxicological and
Clinical Data - VIEW
Gastrointestinal Response and Plasma and Urine Determinations
in Human
Subjects Given Erythritol - VIEW
Plasma and Urine Kinetics of Erythritol after Oral Ingestion by
Healthy
Humans - VIEW
Tolerance to Subchronic, High-Dose Ingestion of Erythritol
in Human
Volunteers - VIEW
|